Examiner Sammantha K Salaz
Grant ratio: 20.3% (13th percentile in Art Unit 2892 among examiners with at least 20 applications). Average office actions per grant: 1.46. Most common rejection type: §103.
Recently active
Last office action in data: October 2026
Examiner record
- Examiner ID
- 100255
- Primary art unit
- 2892
- Work group
- 2890
- Technology center
- 2800
- Applications
- 64
- Granted applications
- 13
- Examiner phone
- (571) 272-2484
- Supervisor
- N. Drew Richards
- Supervisor phone
- (571) 272-1736
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 32 | 50.9% | 2.18 |
| Group | 297 | 52.1% | 1.76 |
| Tech Center | 2,435 | 61.3% | 1.69 |
| USPTO | 16,620 | 51.8% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 3 | 4.7% |
| 1 OA | 21 | 32.8% |
| 2 OAs | 24 | 37.5% |
| 3 OAs | 10 | 15.6% |
| 4 OAs | 4 | 6.3% |
| 5+ OAs | 2 | 3.1% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2025 | 20 | 13 | 65.0% |
| 2026 | 44 | 0 | 0.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 61 | 0.0% | 6.6% | 85.2% | 3.3% |
| Action 2 | 40 | 0.0% | 5.0% | 87.5% | 7.5% |
| Action 3 | 16 | 0.0% | 6.3% | 93.8% | 0.0% |
| Action 4 | 6 | 0.0% | 16.7% | 100.0% | 0.0% |
| Action 5 | 2 | 0.0% | 0.0% | 100.0% | 0.0% |
Section 101 rejections
Last 3 years: 2023-10-23–2026-10-23. All years includes every dated office action in the data.
By year
2025: August memo
0.0%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Oct. 30, 2026.